Abstract
Chagas’ disease is caused by Trypanosoma cruzi, a flagellate protozoan transmitted by an hematophagus reduviid bug. This disease, identified by Dr. Carlos Chagas in 1909 (Chagas 1909, 1910), is a major public health problem in rural areas of Central and South America. Approximately 35 million people are estimated to be at risk of Trypanosoma cruzi infection, and at least 7 million have already been infected (Pan American Health Organization 1970). Human cases have been described from the southern United States to southern Argentina (Marsden 1971). Where Chagas’ disease is endemic, chronic myocarditis is the leading cause of sudden death and heart failure (Laranja et al. 1956). Certain digestive disturbances are also common manifestations of chronic Chagas’ disease (Vampré 1923; Prado 1945; Köberle & Nador 1955).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Adler, S. 1958. The action of specific serum on a strain of Trypanosoma cruzi. Ann. Trop. Med. Parasitol. 52: 282–301.
Afchain, D. & Capron, A. 1971. Analyse immunoelectrophorétique des antigens solubles de Trypanosoma cruzi. Applications à la trypanosomiase expérimentale de la souris. Gaz. Med. Bahia. 71: 7–15.
Alarcón Segovia, S., Andrade, Z.A., Bloom, B.R. et al. 1974. Immunology of Chagas’ disease. Bull. WHO 50: 459–472.
Amato Neto, V., Magalde, C. & Pessoa, S.B. 1964. Intradermoreação para diagnóstico de doença de Chagas com antigeno de Trypanosoma cruzi obtido de cultura de tecido. Rev. Goiana Med. 10: 121–126.
Amato Neto, V. 1968. Doença de Chagas e transfusão de sangue. In Doença de Chagas, J.R. Cançado, Ed.: 130–142. Official Press of Minas Gerais. Belo Horizonte, Brazil.
Andrade, S.G. & Andrade, Z.A. 1966. Doença de Chagas e alterações neuronais no plexo de Auerbach (Estudo experimental em camundongos). Rev. Inst. Med. Trop. São Paulo 8: 219–224.
Andrade, S.G., Carvalho, M.L., Figueira, R.M. & Andrade, Z.A. 1970. Recuparação e caracterização de tripanosomas inoculados em animais imunes (Reinoculação com diferentes cepas do Trypanosoma cruzi). Rev. Inst. Med. Trop. São Paulo 12: 395402.
Andrade, S.G., Figueira, R.M. & Andrade, Z.A. 1968. Influência de infecções repetidas no quadro histopatológico da doença de Chagas experimental. Gaz. Med. Bahia 68: 115–123.
Andrade, Z.A. 1958. Anatomia patológica da doença de Chagas. Rev. Goiana Med 4: 103–119.
Badinez, O.S. 1945. Contribución a la anatomía patológica de la enfermedad de Chagas experimental. Biologica 3: 3–52.
Barbosa, W., Martins, S.P. & Oliveira, R.L. 1973. Nota preliminar sobre trypanosoma variedade hastatus isolado de Phyllostomus hastatus da Gaverna de Fercal-DF Brasil. Rev. Patol. Trop. 2: 367–376.
Barretto, M.P. 1967. Aspectos ecológicos da epidemiología das doenças transmissíveis, com especial referencia às zoonoses. Rev. Bras. Malariol. 19: 633–654.
Behbehani, M.K. 1971. Multiplication of Trypanosoma (Schizotripanum) cruzi in mouse peritoneal macrophages. Trans. R. Soc. Trop. Med. Hyg. 65: 15.
Behbehani, M.K. 1973. Developmental cycles of Trypanosoma (Schizotrypanum) cruzi (Chagas 1909) in mouse peritoneal macrophages in vitro. Parasitology 66: 343–353.
Berrios, A. & Zeledon, R. 1960. Estudio comparativo entre los antigenos de Schizotrypanum cruzi y de Strigomonos oncolpeti en la reacción de fijacion del complemento para enfermedad de Chagas. Rev. Biol. Trop. Univ. Costa Rica 8:225–231.
Bittencourt, A.L. 1969. The congenital transmission of Chagas’ disease as a cause of abortion. Gaz. Med. Bahia 69: 118–122.
Blanchard, M. 1912. Marche de l’infection à Schizotrypanum cruzi chez le cobaye et à la souris. Bull. Soc. Pathol. Exot. 5: 598–599.
Brener, Z. 1965. Comparative studies of different strains of Trypanosoma cruzi. Ann. Trop. Med. Parasitol. 59: 19–26.
Brener, Z. 1966. Chemotherapeutic studies in tissue cultures infected with Trypanosoma cruzi, the mode of action of some active compounds. Ann. Trop. Med. Parasitol. 60: 445–451.
Brener, Z. 1967. Alguns aspectos da imunidade adquirida em camundongos experimentalmente inoculados com Trypanosoma cruzi. Rev. Inst. Med. Trop. São Paulo 9: 233–238.
Brener, Z. 1968. Terapêutica experimental da doença de Chagas. In Doença de Chagas, J.R. Cançado, Ed.: 501–516. Official Press of Minas Gerais. Belo Horizonte, Brazil.
Brener, Z. & Chiari, E. 1963. Variações morfológicas observadas em diferentes amostras de Trypanosoma cruzi Rev. Inst. Med. Trop. São Paulo 5: 220–224.
Brener, Z. & Chiari, E. 1965. Aspects of early growth of different Trypanosoma cruzi strains in culture medium. J. Parasitol. 51: 922–926.
Brener, Z. & Chiari, E. 1967. Suscetibilidade de diferentes amostras de Trypanosoma cruzi a vários agentes quimioterápicos. Rev. Inst. Med. Trop. São Paulo 9: 197–207.
Brener, Z., Chiari, E. & Alvarenga, N.J. 1974. Observations on Trypanosoma cruzi strains maintained over an 8-year period in experimentally inoculated mice. Rev. Inst. Med. Trop. São Paulo 16: 39–46.
Brumpt, E. 1913. Immunité partielle dans les infections à Trypanosoma cruzi, transmission de ce trypanosome par Gmex rotundus. Rôle regulateur des hôtes intermédiaires. Passage à travers la peau. Bull. Soc. Pathol. Exot. 6: 172–176.
Censola, J.A. 1969. Evolución serologica de pacientes con enfermedad de Chagas aguda tratados con Bay 2502. Bol. Chil. Parasitol. 24: 54–59.
Chagas, C. 1909. Nova tripanosomiase humana. Estudos sobre a morfología e o ciclo evolutivo do Schizotrypanum cruzi, n.gen., n.sp., agente etiológico de nova entidade mórbida do homem. Mem. Inst. Oswaldo Cruz Rio de Janeiro 1: 159–218.
Chagas, C. 1910. Nova entidade mórbida do homem. Bras.-Med. 24: 423–428, 433–437, 443.447.
Chagas, C. 1912. Sobre um trypanosomo do tatu, Tatusia novemcincta, transmitido pela Triatoma geniculata. Possibilidade de ser o tatu um depositário do Trypanosoma cruzi no mundo exterior (Nota previa). Bras.-Med. 26: 305–306.
Chagas, C. 1916. Trypanosomiase americana. Forma aguda da moléstia. Mem. Inst. Oswaldo Cruz Rio de Janeiro 8: 37–60.
Chagas, C. 1934. Estado actual da Trypanosomiase americana. Rev. Biol. Hyg., São Paulo 5: 58–64.
Collier, W.A. 1931. Über Immunität bei der Chagas Krankheit der weissen Maus. Z. Hyg. Infektionskr. 112: 88–92.
Cossio, P.M., Laguens, R.P., Diez, C., Szarfman, A., Segal, A. & Arana, R.M. 1974. Chagasic cardiopathy. Antibodies reacting with plasma membrane of striated muscle and endothelial cells. Circulation 50: 1252–1259.
Crowell, P.C. 1923. The acute form of American trypanosomiasis; notes on its pathology, with autopsy report and observations on trypanosomiasis cruzi in animals. Am. J. Trop. Med. 3: 425–454.
Culbertson, J.T. & Kolodny, M.H. 1938. Acquired immunity in rats against Trypanosoma cruzi J. Parasitol. 24: 83–90.
Deane, P.M. & Kloetzel, J.K. 1974. Lack of protection against Trypanosoma cruzi, by multiple doses of Trypanosoma lewisi culture forms. A discussion of some strains of “lewisi.” Exp. Parasitol. 35: 406–410.
Dias, E. 1933. Immunité naturelle des animaux à sang froid vis-à-vis de l’infection par le Trypanosoma cruzi Compt. R. Soc. Biol. 112: 1474–1475.
Dias, E. 1934. Estudios sobre o Schizotrypanum cruzi. Mem. Inst. Oswaldo Cruz Rio de Janeiro 28: 1–110.
Dias, E. 1944. Não receptividade do pombo doméstico à infecção por Schizotrypanum. Mem. Inst. Oswaldo Cruz Rio de Janeiro 40: 181–193.
Dias, E. 1949. Os riscos de propagação da doença de Chagas pelos serviços de transfusão de sangue. Bol. Of. Sanit. Panam. 28: 910–911.
Dias, E. 1956. Chagas-Krankheit. Chagas’ disease. In Welt-Seuchen-Atlas. E. Rodenwaldt, Ed. Vol. 2: 135–140. Falk-Verlag. Hamburg, Federal Republic of Germany.
Feldman, J.D. 1972. Immunological enhancement: a study of blocking antibodies. Adv. Immunol. 15: 167–214.
Fernandes, J.F., Castellani, O. & Okumura, M. 1966. Histopathology of the heart and muscles in mice immunized against Trypanosoma cruzi. Rev. Inst. Med. Trop. São Paulo 8: 151–156.
Ferreira, H.O. & Rassi, A. 1972. Tratamento da fase aguda da doença de Chagas. In International Symposium of Chagas’ Disease: 261–269. Buenos Aires, Argentina.
Fife, E.H. & Kent, J.F. 1960. Protein and carbohydrate complement-fixing antibodies of Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 9: 512–517.
Galliard, H. 1930. Infections à Trypanosoma cruzi chez les animaux splénecto-misés. Bull. Soc. Pathol Exot. 23: 188–192.
Gery, I. & Davies, A.M. 1961. Organ specificity of the heart. II. Immunization of rabbits with homologous heart. J. Immunol. 87: 351–356.
Goble, F.C. 1961a. Experimental therapeutics of Chagas’ disease. Annual International Congress on Chagas’ Disease. 2: 613–633. Rio de Janeiro, Brazil.
Goble, F.C. 1961b. Observations on cross-immunity in experimental Chagas’ disease in dogs. Annual International Congress on Chagas’ Disease. 2: 603–611. Rio de Janeiro, Brazil.
Goble, F.C. 1970. South American trypanosomes. In Immunity to Parasitic Animals. G.J. Jackson, R. Herman & I. Singer, Eds. Vol. 2: 597–689. Appleton-Century-Crofts. New York, N.Y.
Goble, F.C. & Boyd, J.L. 1962. Reticuloendothelial blockage in experimental Chagas’ disease. J. Parasitol. 48: 223–228.
Goble, F.C. Boyd, J.L., Grim, W.M. & Konrath, M. 1964. Vaccination against experimental Chagas’ disease with homogenates of culture forms of Trypanosoma cruzi J. Parasitol. 50 (3, Sec. 2): 19.
Goble, F.C. & Singer, I. 1960. The reticuloendothelial system in experimental malaria and trypanosomiasis. Ann. N. Y. Acad. Sci. 88: 149–171.
Gonçalves, J.M. & Yamaha, T. 1969. Immunochemical polysaccharide from Trypanosoma cruzi J. Trop. Med. Hyg. 72: 39–44.
Gonzalez-Cappa, S.M. & Kagan, I.G. 1969. Agar gel and immunoelectrophoretic analysis of several strains of Trypanosoma cruzi. Exp. Parasitol. 25: 50–57.
Gonzalez-Cappa, S.M., Pesce, V.J., Cantarella, A.I. & Schmunis, G.A. 1974. Trypanosoma cruzi: protection of mice with epimastigote antigens from immunologically different parasite strains. Exp. Parasitol. 35: 179–186.
Gonzalez-Cappa, S.M., Schmunis, G.A., Traversa, O.C., Yanovski, J.F. & Parodi, A.S. 1968. Complement-fixation tests, skin tests, and experimental immunization with antigens of Trypanosoma cruzi prepared under pressure. Am. J. Trop. Med. Hyg. 17: 709–715.
Gonzalez-Cappa, S.M., Vattuone, N.H., Menes, S. & Schmunis, G.A. 1973. Humoral antibody response and Ig characterization of the specific agglutinins in rabbits during experimental American trypanosomiasis. Exp. Parasitol. 34: 32–39.
Guimarães, J.P. & Miranda, A. 1961. Megaesôfago em macaco Rhesus com 10 anos de infeccão chagasica. Annual Brazil, International Congress on Chagas’ Disease. 2: 657–671. Rio de Janeiro, Brazil.
Haberhorn, A. 1972. Quimioterapia experimental. Respuesta de diferentes cepas de Trypanosoma cruzi. International Symposium of Chagas’ Disease: 245–254. Buenos Aires, Argentina.
Hauschka, T.S. 1949. Persistence of strain specific behavior in two strains of Trypanosoma cruzi after prolonged transfer through inbred mice. J. Parasitol. 35:593–599.
Hauschka, T.S., Godwin, N.B., Palmquist J. & Brown, E. 1950. Immunological relationship between seven strains of Trypanosoma cruzi and its application in the diagnosis of Chagas’ disease. Am. J. Trop. Med. Hyg. 30: 1–16.
Hoare, C.A. 1972. The Trypanosomes of Mammals. Blackwell Scientific Publications. Oxford, England.
Hoff, R. 1975. Killing in vitro of Trypanosoma cruzi by macrophages from mice immunized with Trypanosoma cruzi or BCG, and absence of cross-immunity on challenge in vivo J. Exp. Med. 142: 299–311.
Howard, J.E. & Rubio, M. 1968. Enfermedad de Chagas congenita. I. Estudio clinico y epidemiologico de 30 casos. Bol. Chil. Parasitol. 23: 107–112.
Hungerer, K.D. & Enders, B. 1972. Vaccination against Chagas’ disease. Mimeographed paper.
Jaffe, R. 1959. Autoallergische Herzveränderungen. Arzneim-Forsch. 9: 657.
Johnson, P., Neal, R.A. & Gall, D. 1963. Protective effect of killed trypanosome vaccines with incorporated adjuvants. Nature (Lond.). 200: 83.
Kagan, I.G. & Norman, L. 1960. Immunologic studies of Trypanosoma cruzi I. Susceptibility of CFW stock mice for the Tulahuen strain of Trypanosoma cruzi. J. Infect. Dis. 107: 165–167.
Kagan, I.G. & Norman, L. 1961. Immunologic studies of Trypanosoma cruzi. III. Duration of acquired immunity in mice initially infected with a North American strain of Trypanosoma cruzi. J. Infect. Dis. 108: 213–217.
Kagan, I.G. & Norman, L. 1962. Immunologic studies of Trypanosoma cruzi. IV. Serial transfer of Trypanosoma cruzi organisms from immune to nonimmune mice. J. Parasitol. 48: 584–588.
Kierszenbaum, F., Ivanyi, J. & Budzko, D. 1976. Mechanisms of natural resistance to trypanosomal infection. Role of complement in avian resistance to Trypanosoma cruzi infection. Immunology 30: 1–6.
Kierszenbaum, F., Knecht, E., Budzko, D. & Pizzimenti, M.C. 1974. Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi. J. Immunol. 112: 1839–1844.
Kilgour, V. & Godfrey, D.G. 1973. Species-characteristic isoenzymes of two aminotransferases in trypanosomes. Nat. New Biol. 244: 69–70.
Köberle, F. 1957. Patogenia da moléstia de Chagas. Estudio dos orgãos musculares ocos. Rev. Goiana Med. 3: 155–180.
Köberle, F. 1959. El mal de Chagas. Enfermedad del sistema nervioso. Rev. Med. Cordoba 47: 105–133.
Köberle, F. 1968. Chagas’ disease and Chagas syndromes: the pathology of American trypanosomiasis. Adv. Parasitol. 6: 63–116.
Köberle, F. & Nador, E. 1955. Etiologia e patogenia do megaesôfago no Brasil. Rev. Paul. Med. 47: 643–661.
Kolodny, M.H. 1939. The transmission of immunity in experimental trypanosomiasis (Trypanosoma cruzi) from mother rats to their offspring. Am. J. Hyg. 30: 19–39.
Kozma, C., Jaffe, R. & Jaffe, W.F. 1960. Estudo experimental sobre a patogenia das miocardites. Arq. Bras. Cardiol. 13: 155–161.
Krettli, A.V. & Brener, Z. 1976. Protective effects of specific antibodies in Trypanosoma cruzi infections. J. Immunol 116: 755–760.
Laranja, F.S., Dias, E., Nobirega, G. & Miranda, A. 1956. Chagas’ disease. A clinical, epidemiological and pathologic study. Circulation 14: 1035–1060.
Leichuck, R.A., Patrucco, A. & Manni, J.A. 1974. Studies of cellular immunity in Chagas disease: effect of glutaraldehyde-treated specific antigen on inhibition of leukocyte migration. J. Immunol. 112: 1578–1581.
Lugones, H.S. 1972. Tratamiento de la enfermedad aguda. Experiencia Santiago del Estero. International Symposium of Chagas’ Disease: 255–259. Buenos Aires, Argentina.
Marsden, P.D. 1971. South American trypanosomiasis (Chagas’ disease). Int. Rev. Trop. Med. 4: 97–121.
Mayer, M. & Rocha-Lima, H. 1914. Zum Verhalten von Schizotrypanum cruzi in Warm Blutern und Arthropoden. Arch. Schiffs-Tropenhyg. 18: 101–106.
Mazza, S. 1943. Naturaleza histopatológica de reacciones alérgicas cutáneas, provocadas en chagásicos con Usados de cultivos de Schizotrypanum cruzi. Univ. Buenos Aires, Mision Estud. Pat. Reg. Argent. 64: 3–143.
Mazza, S. & Jörg, M.E. 1936. Infección natural mortal por Schizotrypanum cruzi en cachorro de perro “Pila” de Jujuy. 9. Reunión de Sociedad Argentina de Patología Regional: Mendoza, Argentina. 1: 365–411.
Menezes, H. 1965. The use of adjuvants in the vaccination of mice with lyophilized Trypanosoma cruzi. Hospital (Rio de Janeiro) 68: 1341–1346.
Menezes, H. 1968. Protective effect of an avirulent (cultivated) strain of Trypanosoma cruzi against experimental infection in mice. Rev. Inst. Med. Trop. São Paulo 10: 1–4.
Menezes, H. 1969a. Active immunization of dogs with a non-virulent strain of Trypanosoma cruzi. Rev. Inst. Med. Trop. São Paulo 11: 258–263.
Menezes, H. 1969b. Active immunization of mice with the avirulent Y strain of Trypanosoma cruzi against heterologous virulent strains of the same parasite. Rev. Inst. Med. Trop. São Paulo 11: 335–342.
Menezes, H. 1969c. Lesões histológicas do coração em caes “vacinados” com uma cepa avirulenta de Trypanosoma cruzi. Rev. Bras. Med. 26: 281–283.
Menezes, H. 1971. Aplicação de vacina viva avirulenta de Trypanosoma cruzi em séres humanos (nota prévia). Rev. Inst. Med. Trop. São Paulo 13: 144–154.
Menezes, H. 1972. Imunização ativa contra a trypanosomose americana. Med Rev. Cent. Acad. Rocha Lima (CARL) Hosp. Clin. Fac. Med. Ribeirao Preto Univ. São Paulo 5: 85–93.
Moore, D.V. 1957. Antigen relationship of certain hemoflagellates as determined by the Ouchterlony gel diffusion technique. J. Parasitol. 43 (Suppl.):16
Mott, K.E. 1972. American trypanosomiasis. In Infectious Diseases, Hoeprich, P.D. Ed.: 1065–1072 Harper & Row. New York, MY.
Muniz, J. 1930. Del uso del antígeno Watson, Trypanosoma equiperdum, en la reacción de desviación del complemento en la enfermedad de Chagas. 5. Reunión de la Sociedad Argentina de Patología Regional del Norte: Jujuy, Argentina. 2: 897–901.
Muniz, J. 1962. Imunidade na Doença de Chagas (Trypanosomiasis Americana). Mem. Inst. Oswaldo Cruz Rio de Janeiro 60: 103–147.
Muniz, J. 1968. Da importância das reações de âmbito imunológico na patogenia da doença de Chagas. Rev. Goiana Med. 14: 185–191.
Muniz, J. & Borriello, A. 1945. Estudio sobre a ação litica de diferrentes sôros sobre as formas de cultura e sanguícolas do “Schizotrypanum cruzi.” Rev. Bras. Biol. 5: 563–576.
Muniz, J. & Freitas, G. 1944. Contribuição para o diagnóstico da doença de Chagas. II. Isolamento de polisacardieos de Schizotrypanum cruzi e de outros tripanosomideos, seu comportamento nas reações de precipitação, de fixação de complemento e de hipersensibilidade. Os testes de floculação. (Sublimado e formol-gel.) Rev. Bras. Biol 4: 421–438.
Muniz, J. & Freitas, G. 1946. Estudios sobra a imunidade humoral na doença de Chagas. Bras-Med. 60: 337–341.
Muniz, J., Nobrega, G. & da Cunha, M. 1946. Ensaios de vacinação preventiva e curativa nas infecções pelo Schizotrypanum cruzi. Mem. Inst. Oswaldo Cruz Rio de Janeiro 44: 529–541.
Muniz, J. & Penna Azevedo, A. 1947. Novo conceito da patogenia de “doença de Chagas” trypanosomiasis americana; inflamação alérgica granulomatoide (a), e miocardite hiperergica (b), produzida em “rhesus” (Macaca mullata) inoculados com formas mortas de cultivo de Schizotrypanum cruzi (Nota previa). Hospital (Rio de Janeiro) 32: 165–183.
Nery-Guimarães, F. 1972. A refratariedade das aves ao Trypanosoma (S.) cruzi. I. Ausência de passagem para o sangue; duração da viabilidade e destruição dos parasitas na pele. Mem. Inst. Oswaldo Cruz Rio de Janeiro 70: 37–48.
Nery-Guimarães, F. & Lage, H.A. 1972. A refratariedade das aves ao Trypanosoma (S.) cruzi. II. Refratariedade das galinhas desde o nascimento; persistência da refratariedade após bursectomia; infecções em ovos embrion-ados. Mem. Inst. Oswaldo Cruz Rio de Janeiro 70: 97–107.
Norman, L. & Kagan, LG. 1960. Immunologic studies on Trypanosoma cruzi. II. Acquired immunity in mice infected with avirulent American strains of Trypanosoma cruzi. J. Infect. Dis. 107: 168–174.
Nussenzweig, V., Deane, L.M. & Kloetzel, J. 1962. Diversidade na constituição antigênica de amostras de Trypanosoma cruzi isoladas do homem e de gambás. (Nota preliminar.) Rev. Inst. Med. Trop. São Paulo 4: 409–410.
Nussenzweig, V., Deane, L.M. & Kloetzel, J. 1963a. Differences in antigenic constitution of strains of Trypanosoma cruzi. Exp. Parasitol. 14: 221–232.
Nussenzweig, V. & Goble, F.C. 1966. Further studies on the antigenic constitution of strains of Trypanosoma (Schizotrypanum) cruzi. Exp. Parasitol. 18: 224–230.
Nussenzweig, V., Kloetzel, J. & Deane, L.M. 1963b. Acquired immunity in mice infected with strains of immunological types A and B of Trypanosoma cruzi. Exp. Parasitol 14: 233–239.
Pan American Health Organization. 1970. Report of a study group on Chagas’ disease. Pan Am. Health Organ. Sci. Publ. no. 195.
Pessoa, S.B. 1958. Hospedeiros vertebrados (não humanos) do Trypanosoma cruzi. Rev. Goiana Med. 4: 83–101.
Pessoa, S.B. & Cardoso, C.A. 1942. Nota sobre a imunidade cruzada na leishmaniose tegumentar e na moléstia de Chagas. Hospital (Rio de Janeiro) 21: 187–193.
Phillips, N.R. 1960. Experimental studies on the quantitative transmission of Trypanosoma cruzi: Considerations regarding the standardization of materials. Ann. Trop. Med. Parasitol. 54: 60–70.
Pizzi, T. 1961. Inmunología de la enfermedad de Chagas: Estado actual del problema. Bol Of. Sanit. Panam. 51: 450–464.
Pizzi, T. & Knierim, F. 1955. Modificaciones del bazo en relacion con la tasa de anticuerpos circulantes en ratones experimentalmente infectados con Trypanosoma cruzi. Bol Chil. Parasitol 10: 42–49.
Pizzi, T. & Prager, R. 1952. Inmunidad a la sobreinfeccion inducida mediante cultivos de Trypanosoma cruzi de virulencia atenuada. Bol. Inform. Parasitol Chil 7:20–21.
Pizzi, T. & Rubio, M. 1955. Aspectos celulares de la inmunidad en la enfermedad de Chagas. Bol Chil Parasitol 10: 5–9.
Pizzi, T., Rubio, M. & Knierim, F. 1954. Inmunología de la enfermedad de Chagas. Bol. Chil Parasitol 9: 35–47.
Prado, A.A. 1945. Mal de engasgo ou doença de Chagas? (Bloqueio auriculo-ventricular total.) São Paulo Med. 18: 95–112.
Prath, A.R. 1968. Formas clinicas da doença de Chagas. In Doença de Chagas, Cançado, J.R., Ed.: 344–358. Impr. Ofic. Estado de Minas Gerais. Belo Horizonte, Brazil.
Prath, A.R. 1973. Implicações epidemiológicas e socio-econômicas da doença de Chagas.Bras.-Med. 9: 69–71.
Rego, S.F.M. 1959. Estado das lesões provacadas pelo Trypanosoma cruzi Chagas, 1909, no baco e no fígado do camundongo branco (“mus musculis”), com diversos graus de resistência. J. Bras. Med. 1: 599–674.
Rich, A. 1950. Pathogenesis of Tuberculosis. 2nd ed.: 439–450. C. C Thomas. Springfield, Ill.
Roberson, E.L. & Hanson, W.L. 1974. Transfer of immunity to Trypanosoma cruzi Trans. R. Soc. Trop. Med. Hyg. 68: 338.
Roberson, E.L., Hanson, W.L. & Chapman, W.L. 1973. Trypanosoma cruzi: effects of anti-lymphocyte serum in mice and neonatal thymectomy in rats. Exp. Parasitol. 34: 168–180
Romana, O. 1944. Contribuição ao conhecimento da patogenia da trypano-somiase americana (Período inicial da infecção). Mem. Inst. Oswaldo Cruz Rio de Janeiro. 39: 253–264.
Rubio, M. 1954. Estudio de los factores que intervienen en la virulencia de una cepa de Trypanosoma cruzi. Acción de la cortisona en la capacidad de invasión y multiplicación de parasito. Biologica 20: 89–125.
Rubio, M. 1956. Actividad litica de sueros normales sobre formas de cultivo e sanguíneas de Trypanosoma cruzi. Bol. Chil Parasitol. 11: 62–69.
Salgado, J.A., Garcez, P.N., Oliveira, C.A. & Galizzi, J. 1962. Revisão clínica atual do primeiro caso humano descrito de doença de Chagas. Rev. Inst. Med. Trop. São Paulo 4: 330–337.
Santos, R.R. 1973. Contribuição ao estudo da imunidade na fase aguda da doença de Chagas experimental. Rev. Patol. Trop. 2: 433–463.
Santos-Buch, C.A. & Teixeira, A.R.L. 1974. The immunology of experimental Chagas’ disease. 3. Rejection of allogeneic heart cells in vitro. J. Exp. Med. 140: 38–53.
Seah, S. 1970. Delayed hypersensitivity in Trypanosoma cruzi infection. Nature (Lond.)225: 1256–1257.
Seah, S. & Marsden, P.D. 1969. The protection of mice against a virulent strain of Trypanosoma cruzi by previous inoculation with an avirulent strain. Ann. Trop. Med. Parasitol. 63: 211–214.
Seah, S.K., Marsden, P.D., Voller, A. & Pettit, L.E. 1974. Experimental Trypanosoma cruzi infection in rhesus monkeys—the acute phase. Trans. R. Soc. Trop. Med. Hyg. 68: 63–69.
Segura, E.L., Cura, E.N., Paulone, I, Vasquez, C. & Cerisola, J.A. 1974. Antigenic makeup of subcellular fractions of Trypanosoma cruzi. J. Protozool. 21:571–574.
Seneca, H. & Peer, P. 1963. Immunochemistry of Trypanosoma cruzi and immunochemotherapy of experimental Chagas’ disease. Antimicrob. Agents Chemother. 3: 560–565.
Seneca, H. & Peer, P. 1966. Immuno-biological properties of chagastoxin (lipopolysaccharide). Trans. R. Soc. Trop. Med. Hyg. 60: 610–620.
Seneca, H., Peer, P. & Hampar, B. 1966. Active immunization of mice with chagastoxin. Nature (Lond.) 209: 309–310.
Souza, M. doC, Reis, A.P., Da Silva, W.D. & Brener, Z. 1974. Mechanism of acquired immunity induced by Leptomonas pessoai against Trypanosoma cruzi in mice. J. Protozool. 21: 579–584.
Souza, M. doC. & Roitman, I. 1971. Protective effect of Leptomonas pessoai against the infection of mice by Trypanosoma cruzi. Rev. Microbiol. 2: 187–189.
Souza Campos, E. 1927. Estudos sobre uma raça neurotrópica de Trypanosoma cruzi. An. Fac. Med. Univ. São Paulo 2: 197–201.
Taliaferro, W.H. & Pizzi, T. 1955. Connective tissue reaction in normal and immunized mice to a reticulotropic strain of Trypanosoma cruzi. J. Infect. Dis. 96: 199–226.
Tanowitz, H., Wittner, M., Kress, Y. & Bloom, B. 1975. Studies of in vitro infection by Trypanosoma cruzi, I. Ultrastructural studies on the invasion of macrophages and L-cells. Am. J. Trop. Med. Hyg. 24: 25–33.
Tarrant, C.J., Fife Jr., E.H. & Anderson, RJ. 1965. Serological characteristics and general chemical nature of the in vitro exoantigens of Trypanosoma cruzi. J. Parasitol. 51:277–285.
Teixeira, A.R.L., Roters, F.A. & Mott, K.F. 1970. Acute Chagas’ disease. Gaz. Med. Bahia 3: 176–186.
Teixeira, A.R.L. & Santos-Buch, C.A. 1974. The immunology of experimental Chagas’ disease. I. Preparations of Trypanosoma cruzi antigens and humoral antibody response to these antigens. J. Immunol. 113: 859–869.
Teixeira, A.R.L. & Santos-Buch, C.A. 1975. The immunology of experimental Chagas’ disease. II. Delayed hypersensitivity to Trypanosoma cruzi antigens. Immunology 28: 401–410.
Teixeira, A.R.L., Teixeira, M.L. & Santos-Buch, C.A. 1975. The immunology of experimental Chagas’ disease in man. IV. The production of lesions in rabbits like those of chronic Chagas’ disease in man. Am. J. Pathol. 80: 163–180.
Torres, C.B.M. 1930. Patogénia de la miocarditis crónica en la enfermedad de Chagas. 5. Reunión de la Sociedad Argentina de Patologia Regional del Norté Jujuy, Argentina. 2: 902–916.
Torres, C.B.M. & Tavares, B.M. 1958. Miocardite no macaco Cebus após inoculaçôes repetidas com Schizotrypanum cruzi. Mem. Inst. Oswaldo Cruz Rio de Janeiro 56: 85–152.
Tschudi, E.I., Anziano, D.F. & Dalmasso, A.P. 1972. Lymphocyte transformation in Chagas disease. Infect. Immun. 6: 905–908.
Vampré, E. 1923. Terceira contribuição ao estudo do “mal de engasgo.” Bol. Soc. Med. Or. São Paulo 6: 75–88.
Vianna, G.O. 1911. Contribuição para o estudo da Anatomia Patólogica da “moléstia de Carlos Chagas.” Mem. Inst. Oswaldo Cruz Rio de Janeiro 3: 276–294.
Vickerman, K. 1974. Antigenic variation in African trypanosomes. In Parasites in the Immunized Host: Mechanisms of Survival. Ciba Foundation Symposium 25 (new series), Porter, R., & Knights, J. Eds.: 53–80. Associated Scientific Publishers. Amsterdam, The Netherlands.
Vickerman, K. & Luckins, A.G. 1969. Localization of variable antigens in the surface coat of Trypanosoma brucei using ferritin-conjugated antibody. Nature (Lond.) 224: 1125–1126.
Villela, E. 1925. Variação do poder patogênico do “Trypanosoma cruzi” (raça neurotropica). Sci. Med. 3: 147–148.
Voller, A. & Shaw, J.J. 1965. Immunological observations on an antiserum to Trypanosoma cruzi. Z. Tropenmed. Parasitol. 16: 181–187.
von Brand, T., Tobie, E.J., Kissling, R.E. & Adams, G. 1949. Physiological and pathological observations on four strains of Trypanosoma cruzi J. Infect. Dis. 85: 5–16.
Yanovsky, J.F. & Albado, E. 1972. Humoral and cellular response to Trypanosoma cruzi infection. J. Immunol 109: 1159–1161.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Teixeira, A.R.L. (1977). Immunoprophylaxis Against Chagas’ Disease. In: Miller, L.H., Pino, J.A., McKelvey, J.J. (eds) Immunity to Blood Parasites of Animals and Man. Advances in Experimental Medicine and Biology, vol 93. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-8855-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-8855-9_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-8857-3
Online ISBN: 978-1-4615-8855-9
eBook Packages: Springer Book Archive